Results 181 to 190 of about 2,037,045 (319)
Peripheral-central immune interactions in Parkinson's disease: insights into innate and adaptive immunity. [PDF]
Tumpa JJ +3 more
europepmc +1 more source
Peripheral conduction rate in the sympathetic nervous system of man
E. A. Carmichael +3 more
openalex +2 more sources
ON THE CLINICAL RECOGNITION OF STRUCTURAL DISEASE OF THE PERIPHERAL VESSELS [PDF]
George Pickering
openalex +1 more source
ABSTRACT Objective Facioscapulohumeral muscular dystrophy type 1 (FSHD1) is a progressive neuromuscular disorder with no approved treatments. Identifying reliable biomarkers is critical to monitor disease severity, activity, and progression. Interleukin‐6 (IL‐6) has been proposed as a candidate biomarker, but longitudinal validation is limited ...
Jonathan Pini +13 more
wiley +1 more source
Bilateral Peripheral Facial Nerve Neuropathy as the Presenting Feature of Primary Sjögren Syndrome: A Case Report. [PDF]
Hanaoka R.
europepmc +1 more source
Prediction Model for Etiologic Differentiation of Isolated Vestibular Syndrome in Emergency Settings
ABSTRACT Objective This study aimed to develop and validate a predictive model for differentiating central from peripheral etiologies in patients with isolated vestibular syndrome (VS). Methods In this multicenter retrospective cohort study, 506 patients with isolated VS from five hospitals were divided into derivation (n = 301) and validation (n = 205)
Guo Wenting +12 more
wiley +1 more source
Peripheral cytokine levels in patients with idiopathic parkinson's disease undergoing subthalamic nucleus deep brain stimulation. [PDF]
Kocabıcak E +8 more
europepmc +1 more source
Atlas of Peripheral Nerve Injuries. [PDF]
W. R. Lyons, Barnes Woodhall
openalex +1 more source
ABSTRACT Background Mitofusin 2 (MFN2) is a major causative gene for axonal Charcot – Marie – Tooth disease type 2A (CMT2A), with a wide phenotypic spectrum. Comprehensive large ‐ scale genotype – phenotype association studies are essential for understanding disease pathogenesis and improved clinical management.
Masahiro Ando +13 more
wiley +1 more source

